Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by Smitty2000on May 13, 2017 7:06pm

140 Views

Post# 26241327

RE:RE:RE:RE:Is anybody following the hemophilia news this wk?

know one knows anything about sernova. they have had just one news report this year.
the sp and volumes of the stock shows us all that no one knows anything at all, or has any interest.

elgin1 wrote: European hemophilia collaboration is unique . They take patients endothelial cells with hemophilia ...correct the gene defect and reintroduce them via Sva pouch back into the patient. So patients own cells are that produce factor 8 are reintroduced to cure hemophilia. So with this treatment no issues with immunosuppressive or encapsulated cells. Quite remarkable gene therapy. Don't know where they are with this European collaboration .

Bullboard Posts

Cannara reports record growth and profitability in Q4 2023